Tessa Romero
Stock Analyst at JP Morgan
(4.2)
Main Sectors:
Top Industries:
16 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ACAD ACADIA Pharmaceutica... | Maintains: Overweight | 34 33 | 21.8 | 51.38% | 10 | Sep 29, 2025 | |
NMRA Neumora Therapeutics | Downgrades: Underweight | n/a | n/a | n/a | 5 | Sep 16, 2025 | |
EWTX Edgewise Therapeutic... | Maintains: Overweight | 40 30 | 15.65 | 91.69% | 10 | Aug 19, 2025 | |
DYN Dyne Therapeutics | Maintains: Neutral | 10 9 | 13.06 | -31.09% | 6 | Jul 15, 2025 | |
BHVN Biohaven | Maintains: Overweight | 68 55 | 15.81 | 247.88% | 7 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 71 53 | 56.97 | -6.97% | 5 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 16 10 | 6.62 | 51.06% | 2 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 38 | 18.63 | 103.97% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 31 | 37.47 | -17.27% | 5 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 29 | 13.73 | 111.22% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 46 | 40.5 | 13.58% | 6 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 7 | n/a | n/a | 5 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 54 55 | 39.61 | 38.85% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 39 36 | n/a | n/a | 4 | Jun 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 140 150 | n/a | n/a | 1 | Mar 2, 2021 |